Matches in SemOpenAlex for { <https://semopenalex.org/work/W2201584088> ?p ?o ?g. }
- W2201584088 endingPage "2104" @default.
- W2201584088 startingPage "2093" @default.
- W2201584088 abstract "// Yunping Pan 1, 2, * , Xu Guo 3, * , Zheng Yang 2 ,* , Shan Chen 1 , Yiyan Lei 4 , Millicent Lin 5 , Liantang Wang 2 , Chongjin Feng 1 , Zunfu Ke 2 1 Department of Stomatology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Province Guangdong, P.R.China 2 Department of Pathology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Province Guangdong, P.R.China 3 Department of Gynecology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Province Guangdong, P.R. China 4 Department of Chest Surgery, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Province Guangdong, P.R.China 5 Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging (CIMI), California NanoSystems Institute (CNSI), University of California, Los Angeles, California, USA * These authors have contributed equally to this work Correspondence to: Zunfu Ke, e-mail: kezunfu@126.com Chongjin Feng, e-mail: fengchongjin2012@126.com Keywords: AEG-1, epithelial-mesenchymal transition, tongue squamous cell carcinoma, Wnt/PCP, metastasis Received: August 07, 2015 Accepted: November 25, 2015 Published: December 12, 2015 ABSTRACT Despite advances in therapy, survival among patients with locally advanced squamous cell carcinoma of tongue (TSCC) and cervical lymph node metastasis remains dismal. Here, we estimated the functional effect of AEG-1 on TSCC metastasis and explored the molecular mechanism by which AEG-1 stimulates epithelial-mesenchymal transition (EMT). We initially found that AEG-1 mRNA levels were much higher in metastatic TSCC than in non-metastatic TSCC and that AEG-1 expression strongly correlates with EMT status. Receiver operating characteristic analysis showed that the combined AEG-1 and EMT statuses are predictive of the survival rate among TSCC patients. In addition, AEG-1 knockdown inhibited EMT in cultured TSCC cell lines and in a xenograft-mouse model. Recombinant AEG-1 activated Wnt/PCP-Rho signaling, and its stimulatory effects on TSCC cell invasiveness and EMT were reversed by an anti-Wnt5a neutralizing antibody or by inhibition of Rac1 or ROCK. These results highlight the critical stimulatory effect of AEG-1 on cancer cell invasiveness and EMT and indicate that AEG-1 may be a useful prognostic biomarker for TSCC patients." @default.
- W2201584088 created "2016-06-24" @default.
- W2201584088 creator A5004216006 @default.
- W2201584088 creator A5013977055 @default.
- W2201584088 creator A5015885592 @default.
- W2201584088 creator A5016629514 @default.
- W2201584088 creator A5028090675 @default.
- W2201584088 creator A5032273680 @default.
- W2201584088 creator A5032437498 @default.
- W2201584088 creator A5052401749 @default.
- W2201584088 creator A5080366436 @default.
- W2201584088 date "2015-12-12" @default.
- W2201584088 modified "2023-10-15" @default.
- W2201584088 title "AEG-1 activates Wnt/PCP signaling to promote metastasis in tongue squamous cell carcinoma" @default.
- W2201584088 cites W1966819064 @default.
- W2201584088 cites W1976561610 @default.
- W2201584088 cites W1979475230 @default.
- W2201584088 cites W1989012283 @default.
- W2201584088 cites W1995480433 @default.
- W2201584088 cites W1998609343 @default.
- W2201584088 cites W2009463105 @default.
- W2201584088 cites W2013891209 @default.
- W2201584088 cites W2014734839 @default.
- W2201584088 cites W2017611603 @default.
- W2201584088 cites W2020680441 @default.
- W2201584088 cites W2026147554 @default.
- W2201584088 cites W2026262319 @default.
- W2201584088 cites W2029980617 @default.
- W2201584088 cites W2032303618 @default.
- W2201584088 cites W2053257956 @default.
- W2201584088 cites W2058148459 @default.
- W2201584088 cites W2061652166 @default.
- W2201584088 cites W2064680449 @default.
- W2201584088 cites W2067704394 @default.
- W2201584088 cites W2070627423 @default.
- W2201584088 cites W2070765312 @default.
- W2201584088 cites W2087367170 @default.
- W2201584088 cites W2101547995 @default.
- W2201584088 cites W2105345155 @default.
- W2201584088 cites W2106248254 @default.
- W2201584088 cites W2106930099 @default.
- W2201584088 cites W2111603981 @default.
- W2201584088 cites W2111630094 @default.
- W2201584088 cites W2113638068 @default.
- W2201584088 cites W2115095574 @default.
- W2201584088 cites W2121291985 @default.
- W2201584088 cites W2146750548 @default.
- W2201584088 cites W2165901622 @default.
- W2201584088 cites W2166296674 @default.
- W2201584088 cites W2167808312 @default.
- W2201584088 cites W2333469504 @default.
- W2201584088 cites W4229861519 @default.
- W2201584088 doi "https://doi.org/10.18632/oncotarget.6573" @default.
- W2201584088 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4811518" @default.
- W2201584088 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26689985" @default.
- W2201584088 hasPublicationYear "2015" @default.
- W2201584088 type Work @default.
- W2201584088 sameAs 2201584088 @default.
- W2201584088 citedByCount "24" @default.
- W2201584088 countsByYear W22015840882016 @default.
- W2201584088 countsByYear W22015840882017 @default.
- W2201584088 countsByYear W22015840882018 @default.
- W2201584088 countsByYear W22015840882019 @default.
- W2201584088 countsByYear W22015840882020 @default.
- W2201584088 countsByYear W22015840882021 @default.
- W2201584088 countsByYear W22015840882022 @default.
- W2201584088 countsByYear W22015840882023 @default.
- W2201584088 crossrefType "journal-article" @default.
- W2201584088 hasAuthorship W2201584088A5004216006 @default.
- W2201584088 hasAuthorship W2201584088A5013977055 @default.
- W2201584088 hasAuthorship W2201584088A5015885592 @default.
- W2201584088 hasAuthorship W2201584088A5016629514 @default.
- W2201584088 hasAuthorship W2201584088A5028090675 @default.
- W2201584088 hasAuthorship W2201584088A5032273680 @default.
- W2201584088 hasAuthorship W2201584088A5032437498 @default.
- W2201584088 hasAuthorship W2201584088A5052401749 @default.
- W2201584088 hasAuthorship W2201584088A5080366436 @default.
- W2201584088 hasBestOaLocation W22015840881 @default.
- W2201584088 hasConcept C121608353 @default.
- W2201584088 hasConcept C126322002 @default.
- W2201584088 hasConcept C137620995 @default.
- W2201584088 hasConcept C142724271 @default.
- W2201584088 hasConcept C143998085 @default.
- W2201584088 hasConcept C185592680 @default.
- W2201584088 hasConcept C2779013556 @default.
- W2201584088 hasConcept C2779744641 @default.
- W2201584088 hasConcept C502942594 @default.
- W2201584088 hasConcept C55493867 @default.
- W2201584088 hasConcept C62478195 @default.
- W2201584088 hasConcept C71924100 @default.
- W2201584088 hasConcept C76419328 @default.
- W2201584088 hasConceptScore W2201584088C121608353 @default.
- W2201584088 hasConceptScore W2201584088C126322002 @default.
- W2201584088 hasConceptScore W2201584088C137620995 @default.
- W2201584088 hasConceptScore W2201584088C142724271 @default.
- W2201584088 hasConceptScore W2201584088C143998085 @default.
- W2201584088 hasConceptScore W2201584088C185592680 @default.
- W2201584088 hasConceptScore W2201584088C2779013556 @default.